Public Release: 

A gut bacterium that attacks dengue and malaria pathogens and their mosquito vectors


Just like those of humans, insect guts are full of microbes, and the microbiota can influence the insect's ability to transmit diseases. A study published on October 23rd in PLOS Pathogens reports that a bacterium isolated from the gut of an Aedes mosquito can reduce infection of mosquitoes by malaria parasites and dengue virus. The bacterium can also directly inhibit these pathogens in the test tube, and shorten the life span of the mosquitoes that transmit both diseases.

George Dimopoulos and colleagues from Johns Hopkins University, USA, had previously isolated Csp_P, a member of the family of chromobacteria, from the gut of Aedes aegypti mosquitoes (which transmit dengue fever) in Panama. In the present study, they examined its actions on both mosquitoes and pathogens, and the results suggest that Csp_P might help to fight malaria and dengue fever at different levels.

The researchers added Csp_P to sugar water fed to mosquitoes and found that the bacteria are able to quickly colonize the gut of the two most important mosquito disease vectors, namely Aedes aegypti and Anopheles gambiae (the latter transmit malaria). Moreover, the presence of Csp_P in the gut reduced the susceptibility of the respective mosquitoes to infection with the malaria parasite Plasmodium falciparum or with dengue virus. And even without gut colonization, exposure to Csp_P through food or breeding water shortened the lifespan of adult mosquitoes and mosquito larvae of both species.

When the researchers tested whether Csp_P could act against the malaria or dengue pathogens directly, they found that the bacterium, likely through production of toxic metabolites, can inhibit growth of Plasmodium at various stages during the parasite's life cycle, and also abolish dengue virus infectivity. In addition, Csp_P can inhibit growth of many other bacteria.

The authors suggest that these toxic metabolites could potentially be developed into therapeutic drugs for malaria and dengue. Overall, they conclude that "its broad-spectrum anti-pathogen properties together with its ability to kill mosquitoes make Csp_P a particularly interesting candidate for the development of novel control strategies for the two most important vector-borne diseases, and they therefore warrant further in-depth study".


Please contact if you would like more information about our content and specific topics of interest.

Please use this URL to provide readers access to the paper: (Link goes live upon article publication)

George Dimopoulos
phone: +1.443.287.0128

Authors and Affiliations:
Jose Luis Ramirez
Sarah M. Short
Ana C. Bahia
Raul G. Saraiva
Yuemei Dong
Seokyoung Kang
Abhai Tripathi
Godfree Mlambo
George Dimopoulos

All affiliated with Bloomberg School of Public Health, Johns Hopkins University, USA

Funding: This work has been supported by National Institutes of Health/National Institute for Allergy and Infectious Disease grants 1R01AI061576-01A1, RO1AI059492, and RO1AI078997; the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation. JLR was supported by an individual F31 NRSA training grant from NIH/NIAID (1F31AI080161-01A1) and by the American Society for Microbiology Robert D. Watkins Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Ramirez JL, Short SM, Bahia AC, Saraiva RG, Dong Y, et al. (2014) Chromobacterium Csp_P Reduces Malaria and Dengue Infection in Vector Mosquitoes and Has Entomopathogenic and In Vitro Anti-pathogen Activities. PLoS Pathog 10(10): e1004398. doi:10.1371/journal.ppat.1004398

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.